Trials / Completed
CompletedNCT01562184
Investigating tDCS as a Treatment for Unipolar and Bipolar Depression
A Controlled Trial of Transcranial Direct Current Stimulation as a Treatment for Unipolar and Bipolar Depression
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- The University of New South Wales · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Transcranial direct current stimulation (tDCS) is a novel treatment approach for depression that has shown promising efficacy in four recent double-blind, randomized, sham-controlled trials (RCT) and a meta-analysis. This study is a RCT of tDCS in depressed patients, testing its efficacy in both unipolar and bipolar depression. Mood, cognitive test performance and biomarkers will be measured during the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sham tDCS device | Sham tDCS |
| DEVICE | Soterix tDCS device | Active tDCS |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2012-03-23
- Last updated
- 2015-12-02
Locations
6 sites across 2 countries: United States, Australia
Source: ClinicalTrials.gov record NCT01562184. Inclusion in this directory is not an endorsement.